https://www.selleckchem.com/products/atn-161.html
Results A total of 114 patients (median pre-scan PSA 0.42 [interquartile range 0.3-1.1] ng/mL) met selection criteria (54% of patients in XXX). Forty-eight (42%) had 18F-fluciclovine-avid lesions. Twelve patients (11%) had positive findings only in the prostate bed, 24 (21%) had positivity only in the pelvis (prostate bed or pelvic nodes), and 24 (21%) had extrapelvic findings. PSA 0.5 ng/mL and GS ≥8 were associated with a higher risk of extrapelvic positivity (p0.5 ng/mL and GS ≥8 are associated with a higher risk of extrapelvic p